BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19233170)

  • 1. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2.
    Charbel Issa P; van der Veen RL; Stijfs A; Holz FG; Scholl HP; Berendschot TT
    Exp Eye Res; 2009 Jun; 89(1):25-31. PubMed ID: 19233170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
    Helb HM; Charbel Issa P; VAN DER Veen RL; Berendschot TT; Scholl HP; Holz FG
    Retina; 2008 Jun; 28(6):808-16. PubMed ID: 18536596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation.
    Zeimer MB; Krömer I; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2010 Sep; 30(8):1282-93. PubMed ID: 20671587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations.
    Zeimer MB; Padge B; Heimes B; Pauleikhoff D
    Retina; 2010 Apr; 30(4):586-95. PubMed ID: 20386096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.
    Degli Esposti S; Egan C; Bunce C; Moreland JD; Bird AC; Robson AG
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6568-75. PubMed ID: 22899764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interocular agreement in melanin and macular pigment optical density.
    Kanis MJ; Berendschot TT; van Norren D
    Exp Eye Res; 2007 May; 84(5):934-8. PubMed ID: 17382319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central retinal thickness is positively correlated with macular pigment optical density.
    Liew SH; Gilbert CE; Spector TD; Mellerio J; Van Kuijk FJ; Beatty S; Fitzke F; Marshall J; Hammond CJ
    Exp Eye Res; 2006 May; 82(5):915-20. PubMed ID: 16380117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
    Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
    Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
    Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lutein and zeaxanthin measured separately in the living human retina with fundus reflectometry.
    van de Kraats J; Kanis MJ; Genders SW; van Norren D
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5568-73. PubMed ID: 18676627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
    Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
    Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular pigment in the human retina: histological evaluation of localization and distribution.
    Trieschmann M; van Kuijk FJ; Alexander R; Hermans P; Luthert P; Bird AC; Pauleikhoff D
    Eye (Lond); 2008 Jan; 22(1):132-7. PubMed ID: 17401321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration.
    Stringham JM; Hammond BR; Nolan JM; Wooten BR; Mammen A; Smollon W; Snodderly DM
    Exp Eye Res; 2008 Nov; 87(5):445-53. PubMed ID: 18778703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterochromatic flicker photometry.
    Bone RA; Landrum JT
    Arch Biochem Biophys; 2004 Oct; 430(2):137-42. PubMed ID: 15369810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular pigment and the edge hypothesis of flicker photometry.
    Bone RA; Landrum JT; Gibert JC
    Vision Res; 2004 Dec; 44(26):3045-51. PubMed ID: 15474577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundus photography for measurement of macular pigment density distribution in children.
    Bour LJ; Koo L; Delori FC; Apkarian P; Fulton AB
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1450-5. PubMed ID: 11980860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular pigment and healthy vision.
    Optometry; 2009 Oct; 80(10):592-8. PubMed ID: 20576249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular pigment optical density in central serous chorioretinopathy.
    Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Helb HM; Rohrschneider K; Holz FG; Scholl HP
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3788-95. PubMed ID: 17652753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.